Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch The Axe Falls, Again and Again

Premium

In the last year, more than 1,300 people have been laid off in the genomics sector as the market slides and staff reductions seem one of the only answers. The companies and their employee losses since last September:

Aclara: 50
Bruker Daltonics: 45
Celera Genomics: 132
Cellomics: 50
Genaissance Pharmaceuticals: 20%
GeneMachines: 20
Genomics Solution: 43
Genset: closed San Diego R&D facility
Incyte: 400
InforMax: 73
Invitrogen: 175, and closed Huntsville, Ala.,
manufacturing center
Large Scale Biology: 58
Lynx Therapeutics: 44
Medichem: 25%
Paradigm: 50
Third Wave Technologies: 75
Valentis: 45
Variagenics: 40
Xanthon: 10
Numbers are approximate.

 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.